| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Arcutis Biotherapeutics, Inc. (ARQT) has 13 insiders with recent SEC Form 4 filings, including 5 buys and 0 sells. ARQT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 740.5K | $19.45M | - | |
| Other | 150.2K | $3.95M | - | |
| Other | 127.6K | $3.35M | - | |
| Other | 120.2K | $3.16M | - | |
| CFO | 86.0K | $2.26M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 4, 2020 | Bain Capital Life Sciences Investors, LLC | 10% Owner | Buy | 294,117 | $17.00 | $4,999,989.00 | +8.0% | |
| Feb 3, 2020 | Orbimed Advisors LLC67 | Director, 10% Owner | Buy | 558,888 | $17.00 | $9,501,096.00 | New | |
| Feb 3, 2020 | Silverstein Jonathan | Director, 10% Owner | Buy | 558,888 | $17.00 | $9,501,096.00 | New |